Device Vascular Screening

Vs-2000

Payments companies reported to CMS as associated with Vs-2000. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$56Kassociated payments (2023-2025)
6clinicians with associated payments
1company reporting

By year

2023 $31K
2024 $8,807
2025 $16K

Payments reported as associated with Vs-2000, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $40K
Nephrology (Internal Medicine) $8,178
Anesthesiology $7,505

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Vs-2000

These are the largest totals companies reported as associated with Vs-2000. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Julio Chirinos Philadelphia, PA Cardiovascular Disease $28,084.22
Raymond Townsend Philadelphia, PA Nephrology (Internal Medicine) $8,178.21
Johnathan Renew Jacksonville, FL Anesthesiology $7,505.25
Iftikhar Kullo Milwaukee, WI Cardiovascular Disease $4,646.72
Matthew Budoff Torrance, CA Cardiovascular Disease $4,500.00
Naomi Hamburg Boston, MA Cardiovascular Disease $3,000.00

Prescribed Vs-2000?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.